Relypsa, Inc. is a development stage biopharmaceutical company leading the discovery and development of novel non-absorbed polymeric drugs for important applications in cardiovascular and renal disease. The Company's lead product candidate is RLY5016, a non-absorbed potassium binder for the management of hyperkalemia. Relypsa is dedicated to discovering additional product candidates through use of its proprietary polymer platform.

Employee Rating

3.3More
TypeSubsidiary
Parent CompanyVifor Pharma
HQRedwood City, CA, US
Founded2007
Websiterelypsa.com
Cybersecurity ratingBMore
Relypsa was founded in 2007 and is headquartered in Redwood City, CA, US

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Relypsa

Patrick Treanor

Patrick Treanor

President Vifor-Relypsa North America
Greg Oakes

Greg Oakes

President
Estela Alvarez

Estela Alvarez

VP Quality and Analytical Developemnt
Deborah Sim

Deborah Sim

Senior Vice President, General Counsel and Head of U.S. Site Operations
Laurie Hastings

Laurie Hastings

Vice President of Human Resources
Todd Ungard

Todd Ungard

Vice President and Chief Commercial Officer
Show more

Relypsa Office Locations

Relypsa has an office in Redwood City
Redwood City, CA, US (HQ)
100 Cardinal Way
Show all (1)

Relypsa Financials and Metrics

Summary Metrics

Founding Date

2007

Total Funding

$352.3 m

Investors

In total, Relypsa had raised $352.3 m. Relypsa is a subsidiary of Vifor Pharma

Relypsa Revenue

Annual
USDFY, 2014FY, 2015

General and administrative expense

27.9m103.1m

R&D expense

50.2m93.3m

Operating expense total

78.1m196.4m

EBIT

(78.1m)(177.9m)
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016

Revenue

12.4m5.2m

Cost of goods sold

78.0k256.0k

Gross profit

12.3m5.0m

Gross profit Margin, %

99%95%
Annual
USDFY, 2014FY, 2015

Cash

30.3m63.7m

Accounts Receivable

425.0k779.0k

Inventories

2.8m5.4m

Current Assets

139.2m256.3m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016

Cash

26.1m121.0m39.4m82.8m43.1m94.7m67.7m90.2m

Accounts Receivable

861.0k117.0k383.0k1.3m902.0k1.1m513.0k1.3m

Prepaid Expenses

1.3m1.0m1.2m2.2m2.3m6.5m7.7m6.6m

Inventories

24.9m31.9m
Annual
USDFY, 2014FY, 2015

Net Income

(27.6m)(178.7m)

Depreciation and Amortization

5.5m2.8m

Inventories

(1.1m)(2.7m)

Accounts Payable

(1.6m)(119.0k)
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016

Net Income

(16.1m)(32.8m)(52.2m)(29.7m)(68.9m)(120.4m)(54.8m)(138.4m)

Depreciation and Amortization

263.0k559.0k2.5m1.9m2.6m3.3m641.0k1.4m

Inventories

(16.0m)(23.0m)

Accounts Payable

(690.0k)(521.0k)(2.1m)1.5m1.1m2.4m3.3m2.1m
USDQ1, 2014

Financial Leverage

1.5 x
Show all financial metrics

Relypsa Cybersecurity Score

Cybersecurity ratingPremium dataset

B

87/100

SecurityScorecard logo

Relypsa Online and Social Media Presence

Embed Graph

Relypsa Frequently Asked Questions

  • When was Relypsa founded?

    Relypsa was founded in 2007.

  • Who are Relypsa key executives?

    Relypsa's key executives are Patrick Treanor, Greg Oakes and Estela Alvarez.

  • How many employees does Relypsa have?

    Relypsa has 233 employees.

  • Who are Relypsa competitors?

    Competitors of Relypsa include KYORIN Pharmaceutical, YiChang HEC ChangJiang Pharmaceutical and Chiesi Group.

  • Where is Relypsa headquarters?

    Relypsa headquarters is located at 100 Cardinal Way, Redwood City.

  • Where are Relypsa offices?

    Relypsa has an office in Redwood City.

  • How many offices does Relypsa have?

    Relypsa has 1 office.